![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Gamba, Sebastian; Camaj, Peter; Heinemann, Volker; Laubender, Rüdiger P.; Wang, Yan; Zhao, Yue; Stintzing, Sebastian; Giessen, Clemens; Boeck, Stefan; Haertl, Christoph; Bruns, Christiane J. und Modest, Dominik P.
(2015):
Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib.
In: Anti-Cancer Drugs, Bd. 26, Nr. 4: S. 371-378
[PDF, 251kB]
Modest, Dominik P.; Schulz, Christoph; Fischer von Weikersthal, Ludwig; Quietzsch, Detlef; Einem, J. C. von; Schalhorn, Andreas; Vehling-Kaiser, Ursula; Laubender, Rüdiger P.; Giessen, Clemens; Stintzing, Sebastian und Heinemann, Volker
(2014):
Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut): analysis of the FIRE1-trial (FuFIRI or mIROX as first-line treatment).
In: Anticancer Drugs, Bd. 25, Nr. 2: S. 212-218
[PDF, 442kB]
Kneidinger, Nikolaus; Giessen, Clemens; Wulffen, Werner von; Milger, Katrin; Schramm, René; Jäger, Gundula; Nitschko, Hans; Striebinger, Hannah; Behr, Jürgen und Neurohr, Claus
(2014):
Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient.
In: International Journal of infectious Diseases, Bd. 28: S. 140-142
[PDF, 277kB]
Stintzing, Sebastian; Fischhaber, Doris; Mook, Charlotte; Modest, Dominik P.; Giessen, Clemens; Schulz, Christoph; Haas, Michael; Böck, Stefan; Michl, Marlies; Stemmler, Joachim; Laubender, Ruediger P. und Heinemann, Volker
(Oktober 2013):
Clinical relevance and utility of cetuximab-related changes in magnesium and calcium serum levels.
In: Anti-Cancer Drugs, Bd. 24, Nr. 9: S. 969-974
[PDF, 372kB]
Giessen, Clemens; Di Gioia, Dorit; Huber, Bruno; Seppi, Bettina; Graser, Anno; Duerr, Hans Roland; Mayr, Doris; Kirchner, Thomas; Rosenwald, Andreas; Forstpointner, Roswitha; Heinemann, Volker; Bogner, Johannes R. und Ostermann, Helmut
(Februar 2012):
Primary effusion lymphoma (PEL) without effusion: a patient case report of a PEL solid variant.
In: Journal of clinical pathology, Bd. 65, Nr. 2: S. 189-90
[PDF, 530kB]
Giessen, Clemens; Fischer von Weikersthal, Ludwig; Hinke, Axel; Stintzing, Sebastian; Kullmann, Frank; Vehling-Kaiser, Ursula; Mayerle, Julia; Bangerter, Markus; Denzlinger, Claudio; Sieber, Markus; Teschendorf, Christian; Freiberg-Richter, Jens; Schulz, Christoph; Modest, Dominik Paul; Moosmann, Nicolas; Aubele, Philipp und Heinemann, Volker
(2011):
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: The AIO KRK 0110 Trial/ML22011 Trial.
In: BMC Cancer
11:367
[PDF, 533kB]